They need to make this kit generic to monetarily capitalize on this invention. May bring in as much revenue as the drugs?
PE of 10 in a growing biotech is very cheap. Everyone keeps saying how Gilead is cheap and it's PE is 13.5. This stock has much more to run.
So I guess everything comes down to Phase III results. Personally I don't know the chances of whether results are good or not. Based on the PR I understood Cipher doesn't pay a cent until US approval. Am I wrong on that?? If they are paying $1M up front regardless then they must be very confident of approval and of which I would considering investing, otherwise it's a binary event and you might as well bet you rmoney on a roulette table.
If CELG is cheap then I guess GILD is free at about 1/4 of the PE. I do own both but expect that GILD has more upside at this point as this has run the last 6 monthe whereas GILD hasn't.
If every stock ran to analyist's target then we'd all be rich. Anyone else knwo their plan for making revenue and/or raising funds before they run out of money?
According to Yahoo they have $3.8M in cash and their presentation says their burn rate is $440K per months. So they basically only have 8 months before they are broke. Does anyone know their plans to make or raise funds? It sucks being caught in a stock when they announce a note or debt offering.
GILD is a no brainer at this point and into earnings as they will easily beat estimate and raise guidence.
I would cover your short in premarket while it is still under $100. Japan approval news today will lift this over $101 and higher today. MM's like premarket to be down as a starting point for accumulation.
Should trump any market sell off as this is big news. Guidence will be increased in April 20 earnings call.
Great news! I thought this wasn't expected until the summer. Now GILD can raise guidence in next earnings release. This combined with Canadian providing as part of gov't provided health care and Europe approvals will bring in huge numbers that are not part of weekly script numbers.
Cipher has a complimentary drug that is currently awaiting appoval so they are deeply aware of the Fed approval pipeline and which drugs are of most value.
Hope you're right as I'll be in buying more at this last chance under $98 sale before blow out earnings runup. GILD has a lot of catching up to do versus bio index now that they have proven that there isn't any worthy competition, and scripts are beating all estimates.
Can't help but notice this stock hitting year highs while everything else is tanking. Something is in the works!!
Nobody that lives in a first world country is going to be willing to risk their health by using a fake drug from a third world country. What's Barrons motive for printing this trash?
It's not a secret that hedge funds, institutions etc have been accumulating GILD lately in an effort to be in early and for the long run (now that HepC dominance is proven and price issues resolved) so why doesn't the stock price reflect this high demand for GILD stock. If you understand how the Market Makers (MM) provide GILD stock to the Brokers/Institutions (BI) then you'll understand why. The MMs job is to provide an orderly market with liquidity and to provide stock to their clients (BIs) at a competitive price. So what happens is the BI will call the MM and say they want, lets say 10K GILD shares, so the MM will either sell from their inventory or provide shares shares it doesn't have which puts the MM in a short position. The MM doesn't necessarily want to be in a short position as it can leave them vunerable, however, the worse alternative is to potentially loose a client. So the 10K shares are provided to the BI's and the stock price has not increased a cent. At this point the MM wants to cover their short position ASAP as they have privately just witnessed the strong demand for the stock. So what happens during the day is if the market is up the MMs will wait until the afternoon when the volume is less active thus providing them an opportunity to lower it's bid/ask. Using bots they often place large lots on the ask and quickly buy small bids to start a self propelling mid day retracement. A weaker overall afternoon market will often help their cause here. Once the price is lower then they provided they start to buy back inventory and/or cover the shares from the panic retail sellers. Over time the BI's buying slows down as they have accumulated enough shares, then you start to see more positive PR, upgrades etc. As a result the retail investor/trader starts to drive the price upward, often buying their shares back at higher prices which propels GILD to new highs. If you reflect at good stocks like AAPL etc. you'll see this process happens often.
Only 50 shares at $53.36 and 280 at $52.25 so doesn't mean anything. Will be interesting to see what happens to the this and the market on Monday.
Notice none of the media or analyists mentioned this today. Not sure why all the great thing that are going on at GILD are a secret.